Detalhe da pesquisa
1.
3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids.
EMBO J
; 38(12)2019 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036555
2.
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers.
Cancer Immunol Immunother
; 72(9): 2905-2918, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36688995
3.
Genetically engineered CAR NK cells display selective cytotoxicity against FLT3-positive B-ALL and inhibit in vivo leukemia growth.
Int J Cancer
; 145(7): 1935-1945, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30860598
4.
Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice.
Mol Pharm
; 15(9): 3909-3919, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028629
5.
Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells.
Cells
; 13(3)2024 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334638
6.
Co-Expression of an IL-15 Superagonist Facilitates Self-Enrichment of GD2-Targeted CAR-NK Cells and Mediates Potent Cell Killing in the Absence of IL-2.
Cancers (Basel)
; 15(17)2023 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686586
7.
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
Neuro Oncol
; 25(11): 2058-2071, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148198
8.
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599028